0VH.F OVATION SCIENCE I

Healthcare Pharmaceuticals Frankfurt Exchange
0.0050 EUR
Close of Nov 11, 2026
0.0015 0.0235
Market cap
EUR 192K
P/E
-
P/B
3.17x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0VH.F undervalued?

Graham number

The Graham number of OVATION SCIENCE I cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

OVATION SCIENCE I fundamental analysis

No fundamental analysis for OVATION SCIENCE I yet.

OVATION SCIENCE I stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About OVATION SCIENCE I

Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in the United States. The company's patented skin delivery technology Invisicare, a patented polymer-based technology for topical and transdermal skin care products under the Ovation brand name. It also offers cannabis health and wellness products under the Invibe MD name; anti-aging products under the ARLO CBD name; and topical and transdermal creams and lotions with CBD, TH…

Full company profile